- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | AdvanCell & Lilly Expand Collaboration for Targeted Alpha Therapies | ||
| 12.02. | OliX, Lilly Enter Global Licensing Agreement for Cardiometabolic Indications | ||
| 12.02. | Axplora Invests €50M in GLP-1 Manufacturing at France Site | ||
| 12.02. | Alcami Names Tori E. Arens as President of Drug Product | ||
| 12.02. | OnCusp's CUSP06 Receives FDA Fast Track Designation | ||
| 12.02. | Lundbeck's Potential Treatment for Multiple System Atrophy Granted Fast Track Designation | ||
| 11.02. | Alloy Partners with Pfizer to Develop New Antibody Discovery Platform | ||
| 11.02. | Oramed Pharmaceuticals to Spin Off Its Protein Oral Delivery Technology | ||
| 11.02. | Roquette Launches New Coatings Platform | ||
| 11.02. | Novartis to Acquire Anthos Therapeutics | ||
| 11.02. | Telix's Illucix Approved by Danish Medicines Agency | ||
| 11.02. | Frontier Scientific Solutions Begins Construction of cGMP Temp-Controlled Facility at Wilmington International Airport | ||
| 10.02. | AbbVie's EMBLAVEO Approved by FDA for Treatment of Complicated Intra-Abdominal Infections | ||
| 10.02. | Hoth Therapeutics, OnTargetx R&D Partner to Advance Research for Cancer Therapeutic | ||
| 10.02. | Accord, Bio-Thera Partner on Simponi Biosimilar BAT2506 | ||
| 10.02. | PHC & CCRM Partner to Advance Cell & Gene Therapy Manufacturing | ||
| 07.02. | Abbvie 4Q Results | ||
| 07.02. | Viracta Therapeutics Terminates Employees & Winds Down Operations | ||
| 06.02. | Merck 4Q Results | ||
| 06.02. | Amgen 4Q Results | ||
| 06.02. | Lilly 4Q Results | ||
| 06.02. | Pharmapack Europe Announces Award Winners | ||
| 06.02. | PacBio Names Global Head of Sales & Service | ||
| 06.02. | Bio-Rad Launches Dye Label Kits for Antibody Conjugation | ||
| 06.02. | Trilobio Introduces Whole-lab Automation Platform |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
